Meta AnalysisID 6440
通天口服液治疗偏头痛的疗效与安全性：随机对照试验的系统评价与Meta分析
CRD42020200808
What is the clinical efficacy and safety of Tongtian oral liquid in the treatment of migraine?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 6440
- Evidence Id
- 14998
- Core Evidence Id
- 14998
- Source Meta Analysis Id
- 6424
- Herb2 Meta Analysis Id
- HBMA006424
- Crd Id
- CRD42020200808
- Title
- Efficacy and safety of Tongtian oral liquid for migraine: a systematic review and meta-analysis of randomized controlled trials
- Review Question
- What is the clinical efficacy and safety of Tongtian oral liquid in the treatment of migraine?
- Study Type Included
- We will include all randomized controlled trials (RCTs).
- Condition Being Studied
- Migraine according to the internationally acknowledged diagnostic criteria will be included in our analysis.
- Participant
- Participants who are diagnosed with migraine according to the internationally acknowledged diagnostic criteria will be included in our analysis. Participants with headaches caused by other diseases will be excluded. Age must be 18 years old or older, sex and race will not be limited.
- Animal
- Human Disease Modelled
- Intervention
- We will include all randomized controlled trials (RCTs) using Tongtian oral liquid or Tongtian oral liquid plus western medicine in the treatment group. We will include all the studies without any limitation of the publication language. All courses of treatment must be greater than or equal to one week.
- Comparator Control
- We will include all randomized controlled trials (RCTs) using western medicine in the control group, we will include all the studies without any limitation of the publication language. All courses of treatment must be greater than or equal to one week.
- Main Outcome
- The primary outcome measures will be the total effective rate. Measures of effect After treatment, the total effective rate will be assessed by the participants' clinical signs and symptoms.
- Outcome Measure
- Additional Outcome
- The secondary outcomes of our study will include VAS scores, the frequency and duration of attacks, and adverse events or reactions. Measures of effect After treatment, the VAS scores, the frequency and duration of attacks, and adverse events or reactions will be assessed by the participants' clinical signs and symptoms.
- Study Method
- Intervention, Meta-analysis, Systematic review
- Keyword
- Humans; Migraine Disorders; Randomized Controlled Trials as Topic
- Contact
- Yuyao Wang [email protected]
- Organisational Affiliation
- The Third Affiliated Hospital of Beijing University of Chinese Medicine
- Funding Source
- This study was funded by the National Natural Science Foundation of China(81873256) and National Key Research and Development Project ”Research on modernization of traditional Chinese medicine”(2019YFC1709702)
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2020-07-24
- Registration Date
- 2020-08-24
- Anticipated Start Date
- 2020-06-20
- Anticipated Completion Date
- 2020-09-20
- Title Cn
- 通天口服液治疗偏头痛的疗效与安全性：随机对照试验的系统评价与Meta分析
- Title En
- Efficacy and safety of Tongtian oral liquid for migraine: a systematic review and meta-analysis of randomized controlled trials
- Bilingual Status
- complete